Literature DB >> 16801341

Cancer in developing countries: challenges and solutions.

A V Reeler1, H Mellstedt.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16801341     DOI： 10.1093/annonc/mdl981

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

Review 1.  Training global oncologists: addressing the global cancer control problem.

Authors:  Surbhi Grover; Onyinye D Balogun; Kosj Yamoah; Reinou Groen; Mira Shah; Danielle Rodin; Adam C Olson; Jeremy S Slone; Lawrence N Shulman; C Norman Coleman; Stephen M Hahn
Journal:  Front Oncol       Date:  2015-04-08       Impact factor: 6.244

2.  Editorial: "global challenges in radiation oncology".

Authors:  Daniel Grant Petereit; C Norman Coleman
Journal:  Front Oncol       Date:  2015-05-15       Impact factor: 6.244

3.  Cancer incidence in Yemen from 1997 to 2011: a report from the Aden cancer registry.

Authors:  Amen Ahmed Bawazir
Journal:  BMC Cancer       Date:  2018-05-08       Impact factor: 4.430

4.  Epidemiology of Cancers in Zambia: A significant variation in Cancer incidence and prevalence across the nation.

Authors:  Maybin Kalubula; Heqing Shen; Mpundu Makasa; Longjian Liu
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

5.  Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes.

Authors:  Kosj Yamoah; Kwamena Beecham; Sarah E Hegarty; Terry Hyslop; Timothy Showalter; Joel Yarney
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

6.  Cancer registries in four provinces in Turkey: a case study.

Authors:  Frances A Stillman; Michelle R Kaufman; Naseeb Kibria; Sultan Eser; Mark Spires; Yusuf Pustu
Journal:  Global Health       Date:  2012-10-30       Impact factor: 4.185

7.  Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

Authors:  Ebru Tekinturhan; Etienne Audureau; Marie-Pierre Tavolacci; Patricia Garcia-Gonzalez; Joël Ladner; Joseph Saba
Journal:  BMC Health Serv Res       Date:  2013-08-10       Impact factor: 2.655

8.  Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase.

Authors:  Jitendra Kumar Srivastava; Girinath G Pillai; Hans Raj Bhat; Amita Verma; Udaya Pratap Singh
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.